The value and distribution of high-density lipoprotein subclass in patients with acute coronary syndrome.

<h4>Background</h4>High-density lipoprotein (HDL) enhances cholesterol efflux from the arterial wall and exhibits potent anti-inflammatory and anti-atherosclerosis (AS) properties. Whether raised HDL levels will clinically benefit patients with acute coronary syndrome (ACS) and the value...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Li Tian, Chuanwei Li, Yinghui Liu, Yucheng Chen, Mingde Fu
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2014
Materias:
R
Q
Acceso en línea:https://doaj.org/article/725022c4450147e49327573a74e6628c
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:725022c4450147e49327573a74e6628c
record_format dspace
spelling oai:doaj.org-article:725022c4450147e49327573a74e6628c2021-11-18T08:36:15ZThe value and distribution of high-density lipoprotein subclass in patients with acute coronary syndrome.1932-620310.1371/journal.pone.0085114https://doaj.org/article/725022c4450147e49327573a74e6628c2014-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24465490/?tool=EBIhttps://doaj.org/toc/1932-6203<h4>Background</h4>High-density lipoprotein (HDL) enhances cholesterol efflux from the arterial wall and exhibits potent anti-inflammatory and anti-atherosclerosis (AS) properties. Whether raised HDL levels will clinically benefit patients with acute coronary syndrome (ACS) and the value at which these effects will be apparent, however, is debatable. This study examined the HDL subclass distribution profile in patients with ACS.<h4>Methods</h4>Plasma HDL subclasses were measured in 158 patients with established ACS and quantified by two-dimensional gel electrophoresis and immunoblotting. ACS diagnosis was based on symptoms of cardiac ischemia, electrocardiogram (ECG) abnormalities, speciality cardiac enzyme change along with presence of coronary heart disease (CHD) on coronary angiography.<h4>Results</h4>The small-sized preβ1-HDL, HDL3b, and HDL3a levels were significantly higher, and the large-sized HDL2a and HDL2b levels were significantly lower in patients with ACS than in those with stable angina pectoris (SAP) and in normal control subjects. Meanwhile, with an elevation in the low-density lipoprotein cholesterol (LDL-C), fasting plasma glucose (FPG), body mass index (BMI), and blood pressure (BP), and the reduction in the high density lipoprotein cholesterol (HDL-C) levels, the HDL2b contents significantly decreased and the preβ1-HDL contents significantly increased in patients with ACS. The correlation analysis revealed that the apolipoprotein (apo)A-I levels were positively and significantly with all HDL subclasses contents; plasma total cholesterol (TC) and fasting plasma glucose (FPG) levels were inversely associated with HDL2a, and HDL2b. Moreover, the FPG levels were positively related to HDL3c, HDL3b, and HDL3a in ACS patients.<h4>Conclusion</h4>The HDL subclass distribution profile remodeling was noted in the patients with ACS. Plasma lipoprotein and FPG levels, BP, and BMI play an important role in the HDL subclass metabolism disorder for patients with ACS. The HDL subclass distribution phenotype might be useful as a novel biomarker to assist in the risk stratification of patients with ACS.Li TianChuanwei LiYinghui LiuYucheng ChenMingde FuPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 9, Iss 1, p e85114 (2014)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Li Tian
Chuanwei Li
Yinghui Liu
Yucheng Chen
Mingde Fu
The value and distribution of high-density lipoprotein subclass in patients with acute coronary syndrome.
description <h4>Background</h4>High-density lipoprotein (HDL) enhances cholesterol efflux from the arterial wall and exhibits potent anti-inflammatory and anti-atherosclerosis (AS) properties. Whether raised HDL levels will clinically benefit patients with acute coronary syndrome (ACS) and the value at which these effects will be apparent, however, is debatable. This study examined the HDL subclass distribution profile in patients with ACS.<h4>Methods</h4>Plasma HDL subclasses were measured in 158 patients with established ACS and quantified by two-dimensional gel electrophoresis and immunoblotting. ACS diagnosis was based on symptoms of cardiac ischemia, electrocardiogram (ECG) abnormalities, speciality cardiac enzyme change along with presence of coronary heart disease (CHD) on coronary angiography.<h4>Results</h4>The small-sized preβ1-HDL, HDL3b, and HDL3a levels were significantly higher, and the large-sized HDL2a and HDL2b levels were significantly lower in patients with ACS than in those with stable angina pectoris (SAP) and in normal control subjects. Meanwhile, with an elevation in the low-density lipoprotein cholesterol (LDL-C), fasting plasma glucose (FPG), body mass index (BMI), and blood pressure (BP), and the reduction in the high density lipoprotein cholesterol (HDL-C) levels, the HDL2b contents significantly decreased and the preβ1-HDL contents significantly increased in patients with ACS. The correlation analysis revealed that the apolipoprotein (apo)A-I levels were positively and significantly with all HDL subclasses contents; plasma total cholesterol (TC) and fasting plasma glucose (FPG) levels were inversely associated with HDL2a, and HDL2b. Moreover, the FPG levels were positively related to HDL3c, HDL3b, and HDL3a in ACS patients.<h4>Conclusion</h4>The HDL subclass distribution profile remodeling was noted in the patients with ACS. Plasma lipoprotein and FPG levels, BP, and BMI play an important role in the HDL subclass metabolism disorder for patients with ACS. The HDL subclass distribution phenotype might be useful as a novel biomarker to assist in the risk stratification of patients with ACS.
format article
author Li Tian
Chuanwei Li
Yinghui Liu
Yucheng Chen
Mingde Fu
author_facet Li Tian
Chuanwei Li
Yinghui Liu
Yucheng Chen
Mingde Fu
author_sort Li Tian
title The value and distribution of high-density lipoprotein subclass in patients with acute coronary syndrome.
title_short The value and distribution of high-density lipoprotein subclass in patients with acute coronary syndrome.
title_full The value and distribution of high-density lipoprotein subclass in patients with acute coronary syndrome.
title_fullStr The value and distribution of high-density lipoprotein subclass in patients with acute coronary syndrome.
title_full_unstemmed The value and distribution of high-density lipoprotein subclass in patients with acute coronary syndrome.
title_sort value and distribution of high-density lipoprotein subclass in patients with acute coronary syndrome.
publisher Public Library of Science (PLoS)
publishDate 2014
url https://doaj.org/article/725022c4450147e49327573a74e6628c
work_keys_str_mv AT litian thevalueanddistributionofhighdensitylipoproteinsubclassinpatientswithacutecoronarysyndrome
AT chuanweili thevalueanddistributionofhighdensitylipoproteinsubclassinpatientswithacutecoronarysyndrome
AT yinghuiliu thevalueanddistributionofhighdensitylipoproteinsubclassinpatientswithacutecoronarysyndrome
AT yuchengchen thevalueanddistributionofhighdensitylipoproteinsubclassinpatientswithacutecoronarysyndrome
AT mingdefu thevalueanddistributionofhighdensitylipoproteinsubclassinpatientswithacutecoronarysyndrome
AT litian valueanddistributionofhighdensitylipoproteinsubclassinpatientswithacutecoronarysyndrome
AT chuanweili valueanddistributionofhighdensitylipoproteinsubclassinpatientswithacutecoronarysyndrome
AT yinghuiliu valueanddistributionofhighdensitylipoproteinsubclassinpatientswithacutecoronarysyndrome
AT yuchengchen valueanddistributionofhighdensitylipoproteinsubclassinpatientswithacutecoronarysyndrome
AT mingdefu valueanddistributionofhighdensitylipoproteinsubclassinpatientswithacutecoronarysyndrome
_version_ 1718421568344817664